COVID-19: WAYS TO IMPROVE TREATMENT OUTCOMES. TRANSFORMING PERCEPTIONS ABOUT INTENSIVE CARE OF CORONAVIRUS INFECTION
Introduction. Given the lack of effective specific antiviral therapy for COVID-19, the main focus is currently on symptomatic and respiratory support. Almost all hospitalized patients are recommended to undergo oxygen therapy, while the WHO recommended extracorporeal membrane oxygenation for patient...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative Department
2025-05-01
|
| Series: | Клінічна та профілактична медицина |
| Subjects: | |
| Online Access: | https://cp-medical.com/index.php/journal/article/view/600 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849246371814572032 |
|---|---|
| author | Dmytro D. Diachuk Oleg L. Ziukov Volodymyr I. Cherniy Oleksandr V. Naumenko Anatolii I. Denysenko |
| author_facet | Dmytro D. Diachuk Oleg L. Ziukov Volodymyr I. Cherniy Oleksandr V. Naumenko Anatolii I. Denysenko |
| author_sort | Dmytro D. Diachuk |
| collection | DOAJ |
| description | Introduction. Given the lack of effective specific antiviral therapy for COVID-19, the main focus is currently on symptomatic and respiratory support. Almost all hospitalized patients are recommended to undergo oxygen therapy, while the WHO recommended extracorporeal membrane oxygenation for patients with refractory hypoxemia.
Aim. To analyze the complex of intensive care in patients with COVID-19, to evaluate the results of respiratory support and treatment.
Materials and methods. In the SIS «CHIT» SAD for the period from 09/10/2020 to 05/10/2021, 332 patients were treated. There were 22 deaths among the patients. The mortality rate was 6.6%. A total of 327 patients were admitted to the infectious intensive care unit and were treated there. Of these, 277 patients were classified as having moderate disease, and 50 as severe disease. Despite the full range of treatment, including respiratory therapy, the condition of 58 patients with moderate severity and 42 patients classified as severe progressively deteriorated, requiring their transfer to the intensive care unit. Thus, a total of 100 patients were transferred from the infectious intensive care unit to the intensive care unit, of whom 17 (17%) died. In addition, 5 critically ill patients with multiple organ failure syndrome were admitted to the intensive care unit directly from the admission department, who subsequently died. Of the 277 patients with moderate severity and 100 patients classified as severe, 219 and 83 patients, respectively, were successfully treated and discharged home. In patients with COVID-19, SpO2, ECG, heart rate, respiratory rate, blood pressure and body temperature were monitored. Chest CT scan, humoral studies for the diagnosis of cytokine storm (CRP, IL-6, D-dimer) were performed. The experience of treating patients with COVID-19 was analyzed.
Results. The algorithm for providing care for ARF included a step-by-step approach in choosing respiratory therapy for COVID-19. The recommended criterion for the effectiveness of mechanical ventilation, drug therapy and process dynamics is the ratio of total dead space ventilation per minute to total lung ventilation per minute [VD (ml/min)/VE (ml/min)]. The average value of the VD/VE indicator is about 0.3. It has been proven that as the process progresses and the condition worsens, it increases, and as lung function is restored and ARDS is eliminated, it decreases.
Conclusions. Of the 332 patients with COVID-19 hospitalized and treated at the SIS «CIHT» SAD for the period from 01.02.2021 to 01.06.2021, 310 patients were discharged. The mortality rate was 6.6%. |
| format | Article |
| id | doaj-art-f6367c983a444b3da2dbb7789cac06cd |
| institution | Kabale University |
| issn | 2616-4868 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | State Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative Department |
| record_format | Article |
| series | Клінічна та профілактична медицина |
| spelling | doaj-art-f6367c983a444b3da2dbb7789cac06cd2025-08-20T03:58:31ZengState Institution of Science «Research and Practical Center of Preventive and Clinical Medicine» State Administrative DepartmentКлінічна та профілактична медицина2616-48682025-05-015708110.31612/2616-4868.5.2025.09600COVID-19: WAYS TO IMPROVE TREATMENT OUTCOMES. TRANSFORMING PERCEPTIONS ABOUT INTENSIVE CARE OF CORONAVIRUS INFECTIONDmytro D. Diachuk0Oleg L. Ziukov1Volodymyr I. Cherniy2Oleksandr V. Naumenko3Anatolii I. Denysenko4State Institution of Science «Center of innovative healthcare technologies» State Administrative Department, Kyiv, UkraineState Institution of Science «Center of innovative healthcare technologies» State Administrative Department, Kyiv, UkraineState Institution of Science «Center of innovative healthcare technologies» State Administrative Department, Kyiv, UkraineState Institution of Science «Center of innovative healthcare technologies» State Administrative Department, Kyiv, UkraineState Institution of Science «Center of innovative healthcare technologies» State Administrative Department, Kyiv, UkraineIntroduction. Given the lack of effective specific antiviral therapy for COVID-19, the main focus is currently on symptomatic and respiratory support. Almost all hospitalized patients are recommended to undergo oxygen therapy, while the WHO recommended extracorporeal membrane oxygenation for patients with refractory hypoxemia. Aim. To analyze the complex of intensive care in patients with COVID-19, to evaluate the results of respiratory support and treatment. Materials and methods. In the SIS «CHIT» SAD for the period from 09/10/2020 to 05/10/2021, 332 patients were treated. There were 22 deaths among the patients. The mortality rate was 6.6%. A total of 327 patients were admitted to the infectious intensive care unit and were treated there. Of these, 277 patients were classified as having moderate disease, and 50 as severe disease. Despite the full range of treatment, including respiratory therapy, the condition of 58 patients with moderate severity and 42 patients classified as severe progressively deteriorated, requiring their transfer to the intensive care unit. Thus, a total of 100 patients were transferred from the infectious intensive care unit to the intensive care unit, of whom 17 (17%) died. In addition, 5 critically ill patients with multiple organ failure syndrome were admitted to the intensive care unit directly from the admission department, who subsequently died. Of the 277 patients with moderate severity and 100 patients classified as severe, 219 and 83 patients, respectively, were successfully treated and discharged home. In patients with COVID-19, SpO2, ECG, heart rate, respiratory rate, blood pressure and body temperature were monitored. Chest CT scan, humoral studies for the diagnosis of cytokine storm (CRP, IL-6, D-dimer) were performed. The experience of treating patients with COVID-19 was analyzed. Results. The algorithm for providing care for ARF included a step-by-step approach in choosing respiratory therapy for COVID-19. The recommended criterion for the effectiveness of mechanical ventilation, drug therapy and process dynamics is the ratio of total dead space ventilation per minute to total lung ventilation per minute [VD (ml/min)/VE (ml/min)]. The average value of the VD/VE indicator is about 0.3. It has been proven that as the process progresses and the condition worsens, it increases, and as lung function is restored and ARDS is eliminated, it decreases. Conclusions. Of the 332 patients with COVID-19 hospitalized and treated at the SIS «CIHT» SAD for the period from 01.02.2021 to 01.06.2021, 310 patients were discharged. The mortality rate was 6.6%.https://cp-medical.com/index.php/journal/article/view/600covid-19sars-cov-2pulmonary shuntchange in dead space volumeintensive therapy regimentreatmentdrug combination |
| spellingShingle | Dmytro D. Diachuk Oleg L. Ziukov Volodymyr I. Cherniy Oleksandr V. Naumenko Anatolii I. Denysenko COVID-19: WAYS TO IMPROVE TREATMENT OUTCOMES. TRANSFORMING PERCEPTIONS ABOUT INTENSIVE CARE OF CORONAVIRUS INFECTION Клінічна та профілактична медицина covid-19 sars-cov-2 pulmonary shunt change in dead space volume intensive therapy regimen treatment drug combination |
| title | COVID-19: WAYS TO IMPROVE TREATMENT OUTCOMES. TRANSFORMING PERCEPTIONS ABOUT INTENSIVE CARE OF CORONAVIRUS INFECTION |
| title_full | COVID-19: WAYS TO IMPROVE TREATMENT OUTCOMES. TRANSFORMING PERCEPTIONS ABOUT INTENSIVE CARE OF CORONAVIRUS INFECTION |
| title_fullStr | COVID-19: WAYS TO IMPROVE TREATMENT OUTCOMES. TRANSFORMING PERCEPTIONS ABOUT INTENSIVE CARE OF CORONAVIRUS INFECTION |
| title_full_unstemmed | COVID-19: WAYS TO IMPROVE TREATMENT OUTCOMES. TRANSFORMING PERCEPTIONS ABOUT INTENSIVE CARE OF CORONAVIRUS INFECTION |
| title_short | COVID-19: WAYS TO IMPROVE TREATMENT OUTCOMES. TRANSFORMING PERCEPTIONS ABOUT INTENSIVE CARE OF CORONAVIRUS INFECTION |
| title_sort | covid 19 ways to improve treatment outcomes transforming perceptions about intensive care of coronavirus infection |
| topic | covid-19 sars-cov-2 pulmonary shunt change in dead space volume intensive therapy regimen treatment drug combination |
| url | https://cp-medical.com/index.php/journal/article/view/600 |
| work_keys_str_mv | AT dmytroddiachuk covid19waystoimprovetreatmentoutcomestransformingperceptionsaboutintensivecareofcoronavirusinfection AT oleglziukov covid19waystoimprovetreatmentoutcomestransformingperceptionsaboutintensivecareofcoronavirusinfection AT volodymyricherniy covid19waystoimprovetreatmentoutcomestransformingperceptionsaboutintensivecareofcoronavirusinfection AT oleksandrvnaumenko covid19waystoimprovetreatmentoutcomestransformingperceptionsaboutintensivecareofcoronavirusinfection AT anatoliiidenysenko covid19waystoimprovetreatmentoutcomestransformingperceptionsaboutintensivecareofcoronavirusinfection |